All attending UK organisations

UK companies attending BIO Convention as part of the official delegation

UK Exhibitors
Department for International Trade, Scottish Development International, Invest Northern Ireland, Welsh Government

UK Pavilion and Regional Groups:

Northern Health Science Alliance, NPH, NorthWest Ehealth Limited (NPH), Alderley Park, East Midlands Business, MedCity, London and Partners

Other UK companies associated with the delegation*:
Abzena, Albumedix, Albumedix, APTUS CLINICAL, ARCINOVA, Ayva Clinical Trial Services , Biotech and Money, Calchan, Cancer Research Technology, Cello Health Consulting, CIMYM Biosciences, Circassia Pharmaceuticals, CLINICAL ACCELERATOR, Colliers International, Cresset Discovery Services, Crystec, Crystec, East Midlands Business (MIDLANDS ENGINE), EUSA Pharma (UK), Genetic Microdevices, Image Analysis Group, InoCardia, Iontas, Ipsen, Jellagen Pty, King's College London, Lifescience Consultants, Masters Specialty Pharma, MGB Biopharma, MSP / Alderley Park, Northern Health Science Alliance, NorthWest EHealth, Oncimmune, Oppilotech, OxStem, Proximagen, Public Health England, Quay Pharmaceuticals, Sareum, Shield Therapeutics, Stabilitech, Stratophase, Sygnature Discovery, SYNthesis med chem, Therakind, Touchlight

All attending UK companies:
3M Drug Delivery Systems, 4d Pharma, Abzena, Albumedix, Alfacyte,  Alira Health, Almac Discovery, AOP Orphan Pharmaceuticals AG, Apex Healthcare Consulting, Aptus Clinical, Arcinova, Astellas Pharma, AstraZeneca & MedImmune, Aurelia Bioscience, Auspherix, Avacta, Avillion, Ayva Clinical Trial Services, Bactevo, BBI Solutions, BenevolentAI, Bicycle Therapeutics, BioAscent Discovery, BioIndustry Association, Biotech and Money, Biotecnol, Calchan, Cambridge Cognition, Cambridge Enterprise, Cancer Research Technology, CatSci, Cell Medica, Centre for Population Genomic Medicine, Charles River, CIMYM BioSciences, Circassia Pharmaceuticals, Clinical Accelerator, Clintec International, Cobra Biologics, Cognition Kit, Consilient Health, Crescendo Biologics, Cresset, Crystec Pharma, Curileum Discovery,  DC Biosciences, Discuva, DNA Electronics, DPS Group, Edinburgh Molecular Imaging, Egamid,  Elasmogen, Eli Lilly and Company, ERA Consulting Group, Ergomed, EUSA Pharma, Femeda, Finvector Vision Therapies, Formuli, F-Star, FUJIFILM Diosynth Biotechnologies, Fusion Antibodies, GE Healthcare, Genetic Microdevices, Genus, GlaxoSmithKline, GlobalData, Gowling WLG, Hammersmith Medicines Research, Hikma Pharmaceuticals, HistologiX, Horizon Discovery, hVIVO, Illingworth Research, Image Analysis Group, Imanova, Inceptua, Innova Biosciences, Inocardia, Intract Pharma, Iontas, Ipsen Pharma, Isogenica, Jellagan Pty, Johnson & Johnson, Karma Oncology, King's College London, Kymab, Kyowa Kirin International, Locate Therapeutic, London & Partners, Mallinckrodt Pharmaceuticals, Manchester Science Partnerships, Marks & Clerk, Masters Speciality Pharma, Maucher Jenkins, Mawdsley-Brooks, MedCity, Medicines Evaluation Unit, Medpharm, Mereo BioPharma, MGB Biopharma, Micromatrices, Midatech Pharma, Modern Biosciences, MRC Technology, Mundipharma International, mycoBiologics, Nanogenic Solutions, Nature Jobs, Nature Publishing Group, NDA Group, Norgine Ventures, Northern Powerhouse, Northwest EHealth, Novabiotics, Novarum DX, O2h, OMass Technologies, Oncimmune, Oppilotech, Orbit Discovery, Orla Protein Technologies, Orphan Reach, Oxford BioDynamics, Oxford BioMedica, Oxford University Innovation, Oxitec, OxStem, P1vital Products,  PharmaVentures, PHASTAR, PrEP Biopharm, ProAxsis, Proximagen, Psioxus Therapeutics, Public Health England, Pulmocide, Quay Pharmaceuticals, Queen's University Belfast, Randox Biosciences, Redx Pharma, Re-Pharm, ReproCELL Europe, Results Healthcare, Reviral, Sagentia, Sareum, Scottish Development International, Sekisui, SENTINEL ONCOLOGY, Shield Therapeutics, Simbec-Orion Group, Sisaf, Solentim, Solid Form Solutions, Stabilitech, Stratified Medicine Scotland, Stratophase, Substipharm, Summit Therapeutics, Sygnature Discovery, Symbiosis Pharmaceutical Services, Synequanon, Synpromics, SYNthesis Research, The Fulford Group, The Institute of Cancer Research, The NHSA, The Wellcome Trust Sanger Institute, Therakind, TISSUE SOLUTIONS, Touchlight Genetics, Treehill Partners, Trimunocor, Torreya Partners, UCB Inc, University of Bath, University of Edinburgh, Vernalis, Viramal, Viiv Healthcare, Viramal Limited, Warwick Ventures.

Join them here!